Capricor Therapeutics (CAPR) EBT Margin (QoQ) (2011 - 2024)

Capricor Therapeutics (CAPR) EBT Margin (QoQ) (2011 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Capricor Therapeutics 457.86 Mn 457.86 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 572,981.00
Sep 30, 2024 -521,199.00
Jun 30, 2024 -17,061.00
Mar 31, 2024 -40,095.00
Dec 31, 2023 16,046.00
Sep 30, 2023 32,546.00
Jun 30, 2023 -22,174.00
Mar 31, 2023 49,345.00
Dec 31, 2022 75,412.00
Jun 30, 2021 1.01 Mn
Mar 31, 2021 -539,330.00
Dec 31, 2020 6.39 Mn
Sep 30, 2020 -4.98 Mn
Jun 30, 2020 -2.01 Mn
Mar 31, 2020 -50,698.00
Dec 31, 2019 54,926.00
Sep 30, 2019 -70,722.00
Jun 30, 2019 80,440.00
Mar 31, 2019 -80,504.00
Dec 31, 2018 138,350.00